TWO SIGMA INVESTMENTS, LP - NLS PHARMACEUTICS LTD ownership

NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of NLS PHARMACEUTICS LTD
ValueSharesWeighting
Q4 2021$51,00045,8790.00%
Other shareholders
NLS PHARMACEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 5,747,126$3,970,6890.11%
Affinity Asset Advisors, LLC 200,455$140,3190.04%
J. Goldman & Co LP 254,601$178,2210.01%
BANK OF AMERICA CORP /DE/ 90$630.00%
WELLS FARGO & COMPANY/MN 56,549$39,5840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,362$9,9220.00%
Renaissance Technologies 21,100$150.00%
View complete list of NLS PHARMACEUTICS LTD shareholders